Christina M Theodorou1, Sarah C Stokes2, Jordan E Jackson2, Christopher D Pivetti3, Priyadarsini Kumar3, Kaeli J Yamashiro2, Zachary J Paxton3, Lizette Reynaga3, Alicia A Hyllen3, Aijun Wang2, Diana L Farmer2. 1. Department of Surgery, Division of Pediatric General, Thoracic, and Fetal Surgery, University of California Davis Medical Center, Sacramento, CA, United States; Surgical Bioengineering Laboratory, University of California Davis Medical Center, Sacramento, CA, United States. Electronic address: ctheodorou@ucdavis.edu. 2. Department of Surgery, Division of Pediatric General, Thoracic, and Fetal Surgery, University of California Davis Medical Center, Sacramento, CA, United States; Surgical Bioengineering Laboratory, University of California Davis Medical Center, Sacramento, CA, United States. 3. Surgical Bioengineering Laboratory, University of California Davis Medical Center, Sacramento, CA, United States.
Abstract
BACKGROUND: While fetal repair of myelomeningocele (MMC) revolutionized management, many children are still unable to walk independently. Preclinical studies demonstrated that research-grade placental mesenchymal stromal cells (PMSCs) prevent paralysis in fetal ovine MMC, however this had not been replicated with clinical-grade cells that could be used in an upcoming human clinical trial. We tested clinical-grade PMSCs seeded on an extracellular matrix (PMSC-ECM) in the gold standard fetal ovine model of MMC. METHODS: Thirty-five ovine fetuses underwent MMC defect creation at a median of 76 days gestational age, and defect repair at 101 days gestational age with application of clinical-grade PMSC-ECM (3 × 105 cells/cm2, n = 12 fetuses), research-grade PMSC-ECM (3 × 105 cells/cm2, three cell lines with n = 6 (Group 1), n = 6 (Group 2), and n = 3 (Group 3) fetuses, respectively) or ECM without PMSCs (n = 8 fetuses). Three normal lambs underwent no surgical interventions. The primary outcome was motor function measured by the Sheep Locomotor Rating scale (SLR, range 0: complete paralysis to 15: normal ambulation) at 24 h of life. Correlation of lumbar spine large neuron density with SLR was evaluated. RESULTS: Clinical-grade PMSC-ECM lambs had significantly better motor function than ECM-only lambs (SLR 14.5 vs. 6.5, p = 0.04) and were similar to normal lambs (14.5 vs. 15, p = 0.2) and research-grade PMSC-ECM lambs (Group 1: 14.5 vs. 15, p = 0.63; Group 2: 14.5 vs. 14.5, p = 0.86; Group 3: 14.5 vs. 15, p = 0.50). Lumbar spine large neuron density was strongly correlated with motor function (r = 0.753, p<0.001). CONCLUSIONS: Clinical-grade placental mesenchymal stromal cells seeded on an extracellular matrix rescued ambulation in a fetal ovine myelomeningocele model. Lumbar spine large neuron density correlated with motor function, suggesting a neuroprotective effect of the PMSC-ECM in prevention of paralysis. A first-in-human clinical trial of PMSCs in human fetal myelomeningocele repair is underway.
BACKGROUND: While fetal repair of myelomeningocele (MMC) revolutionized management, many children are still unable to walk independently. Preclinical studies demonstrated that research-grade placental mesenchymal stromal cells (PMSCs) prevent paralysis in fetal ovine MMC, however this had not been replicated with clinical-grade cells that could be used in an upcoming human clinical trial. We tested clinical-grade PMSCs seeded on an extracellular matrix (PMSC-ECM) in the gold standard fetal ovine model of MMC. METHODS: Thirty-five ovine fetuses underwent MMC defect creation at a median of 76 days gestational age, and defect repair at 101 days gestational age with application of clinical-grade PMSC-ECM (3 × 105 cells/cm2, n = 12 fetuses), research-grade PMSC-ECM (3 × 105 cells/cm2, three cell lines with n = 6 (Group 1), n = 6 (Group 2), and n = 3 (Group 3) fetuses, respectively) or ECM without PMSCs (n = 8 fetuses). Three normal lambs underwent no surgical interventions. The primary outcome was motor function measured by the Sheep Locomotor Rating scale (SLR, range 0: complete paralysis to 15: normal ambulation) at 24 h of life. Correlation of lumbar spine large neuron density with SLR was evaluated. RESULTS: Clinical-grade PMSC-ECM lambs had significantly better motor function than ECM-only lambs (SLR 14.5 vs. 6.5, p = 0.04) and were similar to normal lambs (14.5 vs. 15, p = 0.2) and research-grade PMSC-ECM lambs (Group 1: 14.5 vs. 15, p = 0.63; Group 2: 14.5 vs. 14.5, p = 0.86; Group 3: 14.5 vs. 15, p = 0.50). Lumbar spine large neuron density was strongly correlated with motor function (r = 0.753, p<0.001). CONCLUSIONS: Clinical-grade placental mesenchymal stromal cells seeded on an extracellular matrix rescued ambulation in a fetal ovine myelomeningocele model. Lumbar spine large neuron density correlated with motor function, suggesting a neuroprotective effect of the PMSC-ECM in prevention of paralysis. A first-in-human clinical trial of PMSCs in human fetal myelomeningocele repair is underway.
Authors: Amy J Houtrow; Elizabeth A Thom; Jack M Fletcher; Pamela K Burrows; N Scott Adzick; Nina H Thomas; John W Brock; Timothy Cooper; Hanmin Lee; Larissa Bilaniuk; Orit A Glenn; Sumit Pruthi; Cora MacPherson; Diana L Farmer; Mark P Johnson; Lori J Howell; Nalin Gupta; William O Walker Journal: Pediatrics Date: 2020-02 Impact factor: 7.124
Authors: Payam Saadai; Yvette S Nout; Jose Encinas; Aijun Wang; Timothy L Downing; Michael S Beattie; Jacqueline C Bresnahan; Song Li; Diana L Farmer Journal: J Pediatr Surg Date: 2011-12 Impact factor: 2.545
Authors: Y Julia Chen; Karen Chung; Christopher Pivetti; Lee Lankford; Sandra K Kabagambe; Melissa Vanover; James Becker; Chelsey Lee; Josephine Tsang; Aijun Wang; Diana L Farmer Journal: J Pediatr Surg Date: 2017-10-12 Impact factor: 2.545
Authors: Erin G Brown; Payam Saadai; Christopher D Pivetti; Michael S Beattie; Jacqueline C Bresnahan; Aijun Wang; Diana L Farmer Journal: J Pediatr Surg Date: 2013-10-05 Impact factor: 2.545
Authors: Laura A Galganski; Kaeli J Yamashiro; Christopher D Pivetti; Benjamin A Keller; James C Becker; Erin G Brown; Payam Saadai; Shinjiro Hirose; Aijun Wang; Diana L Farmer Journal: Fetal Diagn Ther Date: 2020-02-25 Impact factor: 2.587
Authors: Sarah C Stokes; Christina M Theodorou; Jordan E Jackson; Christopher Pivetti; Priyadarsini Kumar; Kaeli J Yamashiro; Zachary J Paxton; Lizette Reynaga; Alicia Hyllen; Aijun Wang; Diana L Farmer Journal: J Pediatr Surg Date: 2021-09-20 Impact factor: 2.549